ZKTeco BioTime Path Traversal Vulnerability
ZKTeco — BioTime
- EPSS (30-day exploitation probability)
- 92.5% · 99.8th percentile · 20 November 2026
- Added to KEV catalog
- 19 May 2025
- Federal remediation due date
- 9 June 2025
- Weakness classification (CWE)
- CWE-22
Is CVE-2023-38950 actively exploited?
Yes. CISA added CVE-2023-38950 to its Known Exploited Vulnerabilities catalog on 19 May 2025, which means there is evidence it has been exploited in the wild. FIRST's EPSS model estimates a 92.5% probability of exploitation activity in the next 30 days, placing it in the 99.8th percentile of all scored CVEs.
How do I fix CVE-2023-38950?
CISA's required action for CVE-2023-38950 is: Apply mitigations per vendor instructions, follow applicable BOD 22-01 guidance for cloud services, or discontinue use of the product if mitigations are unavailable. US federal agencies must remediate it by 9 June 2025; treat that as an outside deadline, not a target.
CISA Description
ZKTeco BioTime contains a path traversal vulnerability in the iclock API that allows an unauthenticated attacker to read arbitrary files via supplying a crafted payload.
Required action
Apply mitigations per vendor instructions, follow applicable BOD 22-01 guidance for cloud services, or discontinue use of the product if mitigations are unavailable.
Notes
https://www.zkteco.com/en/Security_Bulletinsibs ; https://nvd.nist.gov/vuln/detail/CVE-2023-38950
Is this vulnerability present in your environment?
CRS delivers independent VAPT assessments that identify exactly which known-exploited vulnerabilities exist in your network, applications, and infrastructure.
Explore VAPT Services







